ELITE PHARMACEUTICALS INC /NV/

ELTP

ELITE PHARMACEUTICALS INC /NV/

ELTP

Insider Sentiment (TTM):

Last Purchase:2025-07-10Last Sale:2025-10-02Shares Purchased (TTM):0Shares Sold (TTM):800,000

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:500Shares Outstanding:1,072,837,856Institutional Ownership Pct.:0.00%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash	39	30	21	27	22	11	8	10	8	7	6	9
Cash And Cash Equivalents At Carrying Value	-	-	-	-	-	-	-	-	-	7	6	9
Accounts Receivable Net Current	50	60	49	41	36	29	18	21	20	19	16	10
Inventory Net	24	21	25	18	19	16	20	14	14	13	14	15
Prepaid Expense And Other Assets Current	1	1	2	0	1	1	1	0	0	1	1	0
Assets Current	114	112	97	86	78	58	48	45	43	40	37	35
Property Plant And Equipment Net	11	10	10	10	10	10	10	10	11	10	10	10
Finite Lived Intangible Assets Net	5	5	6	6	6	6	7	7	7	6	6	6
Finance Lease Right Of Use Asset	-	1	1	2	2	2	2	2	2	2	0	-
Operating Lease Right Of Use Asset	1	2	2	2	2	2	2	2	2	2	0	0
Deferred Income Tax Assets Net	7	8	10	12	13	18	21	21	22	22	20	19
Other Assets
Restricted Cash Equivalents	0	0	0	0	0	0	0	0	0	0	0	0
Restricted Cash And Cash Equivalents Noncurrent	-	-	-	-	-	-	-	-	-	0	0	0
Security Deposit	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	1	1	1	1	1	1	1	1	1	1	0	0
Assets	140	138	126	117	111	96	91	88	88	84	75	71
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	6	6	7	3	5	3	6	2	3	3	3	4
Accrued Liabilities Current	6	10	6	6	5	4	4	6	6	5	12	11
Contract With Customer Liability Current	-	-	-	-	0	0	0	0	0	0	0	0
Secured Debt Current	0	0	0	0	0	0	0	0	0	0	0	0
Loans Payable Current	0	0	0	0	0	0	0	0	0	0	0	0
Other Loans Payable	-	-	-	-	-	4	4	4	4	4	4	4
Finance Lease Liability Current	-	0	0	0	0	0	0	0	0	0	0	-
Operating Lease Liability Current	1	1	1	1	0	0	0	0	0	0	0	0
Liabilities Current	30	17	13	11	11	12	15	13	14	13	19	19
Contract With Customer Liability Noncurrent	-	-	-	-	-	-	-	-	0	0	0	0
Liabilities Noncurrent
Secured Long Term Debt	1	1	1	1	1	1	1	1	1	1	1	1
Long Term Loans Payable	2	2	2	2	2	2	2	2	2	2	2	2
Finance Lease Liability Noncurrent	-	1	1	1	1	1	1	1	1	1	0	-
Operating Lease Liability Noncurrent	1	1	1	1	1	2	2	2	2	2	-	-
Derivative Liabilities Noncurrent	-	17	28	40	47	25	34	22	9	6	6	3
Liabilities Noncurrent	4	22	33	45	53	31	40	28	16	13	9	7
Liabilities	35	39	46	56	64	43	54	41	30	26	28	26
Stockholders Equity
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital	174	174	174	174	174	173	173	173	173	173	165	165
Treasury Stock Value	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-70	-76	-94	-113	-127	-121	-138	-127	-116	-116	-120	-120
Stockholders Equity	105	99	80	62	48	54	36	47	58	58	46	45
Liabilities And Stockholders Equity	140	138	126	117	111	96	91	88	88	84	75	71
Allowance For Doubtful Accounts Receivable Current	1	1	1	1	1	0	0	0	0	0	0	0
Accumulated Depreciation Depletion And Amortizatio…	18	18	18	18	17	17	17	16	16	16	16	15
Finite Lived Intangible Assets Accumulated Amortiz…	-	-	-	-	-	-	-	-	-	-	0	0
Finance Lease Right Of Use Asset Accumulated Amort…	-	1	1	1	-	1	-	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	1,445	1,445	1,445	1,445	1,445	1,445	1,445	1,445	1,445	1,445	1,445	1,445
Common Stock Shares Issued	1,077	1,077	1,075	1,073	1,068	1,068	1,068	1,068	1,068	1,068	1,018	1,014
Shares Outstanding	1,077	1,077	1,074	1,073	1,068	1,068	1,068	1,068	1,068	1,068	1,018	1,014
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2027	-	-	-	-	-	-	-	-	-	-	-	-
2026	32.08%	20.75%	16.98%	-23.53%	-26.47%	-35.29%	-11.36%	-13.64%	-20.45%	-2.50%	-	-
2025	55.00%	95.00%	150.00%	15.38%	3.85%	-3.85%	-12.73%	-41.82%	-23.64%	-24.66%	-24.66%	-15.07%
2024	100.00%	150.00%	200.00%	16.67%	16.67%	50.00%	-25.00%	-30.00%	-35.00%	-5.00%	0.00%	85.00%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.76	6.45	7.34	8.04	7.23	4.88	3.27	3.52	3.08	3.07	1.94	1.82
Quick Ratio	2.94	5.15	5.28	6.32	5.38	3.42	1.82	2.41	2.06	2.04	1.14	1.00
Working Capital	84.05M	94.72M	83.60M	75.12M	67.10M	45.90M	33.36M	32.44M	29.15M	26.96M	18.00M	15.65M
Leverage & Debt
Debt to Equity	0.33	0.40	0.57	0.90	1.34	0.80	1.49	0.87	0.51	0.45	0.61	0.57
Interest Coverage TTM	-	-	-	-	-	-	56.07	43.13	27.81	18.33	9.51	5.65
Debt Ratio	0.25	0.28	0.36	0.47	0.57	0.44	0.60	0.46	0.34	0.31	0.38	0.36
Efficiency & Turnover
Asset Turnover TTM	1.12	1.27	1.29	1.20	1.06	0.93	0.85	0.90	0.99	0.91	0.74	0.68
Days Sales Outstanding TTM	112.16	109.01	87.24	92.54	98.14	105.67	89.86	81.90	73.30	72.67	83.13	65.49
Receivables Turnover TTM	3.25	3.35	4.18	3.94	3.72	3.45	4.06	4.46	4.98	5.02	4.39	5.57
Per Share Metrics
Diluted EPS TTM	0.05	0.04	0.04	0.01	-0.01	-0.00	-0.02	-0.01	0.02	0.02	0.02	0.02
Free Cash Flow Per Share TTM	0.03	0.02	0.01	0.02	-0.00	0.01	0.00	0.00	0.00	-0.00	-0.00	-0.00
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	43.47%	50.40%	51.06%	52.66%	55.80%	47.70%	44.16%	44.73%	45.27%	46.55%	46.68%	48.67%
Operating Profit Margin TTM	24.78%	32.99%	35.74%	34.31%	35.50%	23.32%	17.39%	20.53%	19.64%	19.05%	14.10%	12.43%
Net Profit Margin TTM	40.19%	30.14%	30.98%	11.33%	-10.26%	-5.13%	-25.70%	-8.98%	29.47%	35.51%	32.87%	43.42%
Growth Metrics
Net Revenue Growth (1Y)	33.72%	77.13%	100.18%	72.67%	58.70%	48.42%	47.91%	73.45%	87.38%	65.79%	42.62%	24.70%
Net Income Growth (1Y)	-623.97%	-1,140.01%	-341.34%	-317.96%	-155.23%	-121.46%	-215.64%	-135.85%	345.28%	464.56%	115.43%	172.72%
EPS Growth (1Y)	-619.65%	-1,135.60%	-340.03%	-317.22%	-155.22%	-120.40%	-209.85%	-134.03%	322.63%	463.15%	115.25%	172.27%
Valuation Metrics
P/E TTM	7.03	8.61	12.12	49.27	-72.11	-108.94	-32.07	-65.22	10.91	7.57	9.13	5.12
P/B TTM	3.80	3.91	6.55	11.14	16.36	8.78	15.83	8.81	3.67	2.65	3.06	2.02
P/S TTM	2.83	2.59	3.76	5.58	7.40	5.59	8.24	5.85	3.22	2.69	3.00	2.22
Market Cap	398.58M	386.22M	526.32M	686.01M	779.91M	470.05M	576.87M	416.63M	213.65M	152.32M	142.07M	91.25M
Enterprise Value	360.05M	358.06M	506.96M	661.23M	760.25M	460.92M	570.90M	409.56M	207.88M	148.21M	137.71M	83.37M
Calculated Values
Free Cash Flow TTM	32.08M	17.61M	12.03M	16.45M	-1.74M	5.83M	4.36M	2.63M	1.03M	-4.04M	-3.31M	-1.08M
Net Debt	-38.53M	-28.16M	-19.36M	-24.78M	-19.66M	-9.12M	-5.97M	-7.06M	-5.78M	-4.10M	-4.36M	-7.88M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-10-02Sale

Owner: Plassche, Douglas

Title: EVP Operations

Shares: 800,000

Price/Share: $0.62

Value: $496,000.00

Shares Owned: 3,500,000

Relationship: Officer

Ownership: Direct

2025-08-22Sale

Owner: Elite, Pharmaceuticals In…

Title: EVP Operations

Shares: 500,000

Price/Share: $0.52

Value: $260,000.00

Shares Owned: 1,800,000

Relationship: Officer

Ownership: Direct

2025-07-10Purchase

Owner: Kirkov, Kirko

Title: Chief Commercial Officer

Shares: 16,366

Price/Share: $0.59

Value: $9,655.94

Shares Owned: 16,366

Relationship: Officer

Ownership: Direct

2025-07-08Sale

Owner: Plassche, Douglas

Title: EVP Operations

Shares: 200,000

Price/Share: $0.58

Value: $116,000.00

Shares Owned: 2,300,000

Relationship: Officer

Ownership: Direct

2024-10-24Sale

Owner: Plassche, Douglas

Title: SVP of Operations

Shares: 333,932

Price/Share: $0.51

Value: $170,305.32

Shares Owned: -

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-10-02	Plassche, Douglas	Officer	EVP Operations	Direct	Sale	800,000	0.62	$496,000.00	3,500,000	4
2025-08-22	Elite, Pharmaceuticals In…	Officer	EVP Operations	Direct	Sale	500,000	0.52	$260,000.00	1,800,000	4
2025-07-10	Kirkov, Kirko	Officer	Chief Commercial Officer	Direct	Purchase	16,366	0.59	$9,655.94	16,366	4
2025-07-08	Plassche, Douglas	Officer	EVP Operations	Direct	Sale	200,000	0.58	$116,000.00	2,300,000	4
2024-10-24	Plassche, Douglas	Officer	SVP of Operations	Direct	Sale	333,932	0.51	$170,305.32	0	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

0.00%

Inst. Shares: 500

Shares Outstanding: 1,072,837,856

2025-12-31

0.00%

Inst. Shares: 500

Shares Outstanding: 1,074,115,101

2025-09-30

0.00%

Inst. Shares: 5,682

Shares Outstanding: 1,071,897,174

2025-06-30

0.00%

Inst. Shares: 5,182

Shares Outstanding: 1,068,363,108

2025-03-31

0.00%

Inst. Shares: 5,182

Shares Outstanding: 1,068,290,368

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	500	1,072,837,856	0.00%
2025-12-31	500	1,074,115,101	0.00%
2025-09-30	5,682	1,071,897,174	0.00%
2025-06-30	5,182	1,068,363,108	0.00%
2025-03-31	5,182	1,068,290,368	0.00%
2023-12-31	82,000	1,014,768,071	0.01%
2023-09-30	82,000	1,013,915,081	0.01%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ELITE PHARMACEUTICALS INC /NV/ (ELTP) — SEC Financial Statements & Analysis

ELITE PHARMACEUTICALS INC /NV/ (ELTP) is a pharmaceutical preparations company, incorporated in NJ. ELITE PHARMACEUTICALS INC /NV/ trades on OTC as: ELTP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ELITE PHARMACEUTICALS INC /NV/ reported a 33.72% year-over-year revenue growth, a Gross Profit Margin of 43.47% (TTM), a Debt-to-Equity ratio of 0.33x, a Price-to-Sales (P/S) ratio of 2.83x (TTM), a Price-to-Book (P/B) ratio of 3.80x (TTM), at a market cap of $398.58M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 33.72%
Gross Profit Margin TTM: 43.47%
Debt To Equity: 0.33x
P/S TTM: 2.83x
P/B TTM: 3.80x
Market Cap: $398.58M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ELITE PHARMACEUTICALS INC /NV/ in?

ELITE PHARMACEUTICALS INC /NV/ (ELTP) operates in the Pharmaceutical Preparations industry.

What is ELTP's market cap?

ELITE PHARMACEUTICALS INC /NV/ (ELTP) has a market capitalization of $398.58M as of 2026-06-30.

What is ELTP's P/E ratio?

ELITE PHARMACEUTICALS INC /NV/ (ELTP)'s trailing twelve month P/E ratio is 7.03x as of 2026-06-30.

What exchange does ELTP trade on?

ELITE PHARMACEUTICALS INC /NV/ (ELTP) trades on the OTC.

Where is ELITE PHARMACEUTICALS INC /NV/ incorporated?

ELITE PHARMACEUTICALS INC /NV/ is incorporated in NJ.